TDF 300mg / FTC 200mg / EFV 600mg, tab.

NST DORATEEF1T-

Valid Article

Former Code(s): -X DORATEEF3T2 DORAZBD0495
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J05AR06
Anatomical Therapeutic Chemical Classification according to WHOCC
The order of this product needs to be justified and is only acceptable under certain conditions.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   

Add Kit To Wishlist

   

TENOFOVIR (TDF)/ EMTRICITABINE (FTC)/ EFAVIRENZ (EFV)

Efavirenz (EFV)-based combinations became non-standard. They are no longer the option of choice in first-line HIV treatment according to the WHO guidelines update 2021. Replaced by dolutegravir (DTG)-based combinations.

Therapeutic Action

Fixed-dose combination (FDC) of three antiretrovirals:

  • nucleotide reverse-transcriptase inhibitors (NRTI): tenofovir + emtricitabine
  • non-nucleoside reverse-transcriptase inhibitor (NNRTI): efavirenz

Indications

HIV infection

Some restricted information has been hidden. Sign in to see this information

Instructions for use

Storage

Below 25ºC